KNOTT DAVID M
Q3 2019 Form 13-F
SYOSSET, NEW YORK
CIK 0000808722
· Institutional investment manager
Consolidated report · includes
1 manager
since Q2 2013
$238.0M Reported Value Total
Reported value
$238.0M
Quarter over quarter
-5.0%
Holdings
116
Top-10 concentration
58.4%
Filing Structure
Reports holdings for
- DORSET MANAGEMENT CORP (not a 13F filer in our records) · File #028-10281 · since Q2 2013 · declared by one filing
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Knott David M
Investment Manager
Filing Navigation
13F Metrics
Loading 13F Metrics
Q3 2019 13F record
Q3 2019 13F filing summary
| Period of report | September 30, 2019 |
|---|---|
| Filed | November 12, 2019 |
| Form | 13F-HR |
| Reported value | $238.0M |
| Positions | 116 |
| Change in reported value | +0.4% |
| New positions | 21 |
| Exited positions | 14 |
| Position turnover | 26.9% |
| Top-10 concentration | 58.4% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2021 13F
Filed Nov 12, 2021
|
147 | $275.2M |
|
Q2 2021 13F
Filed Aug 13, 2021
|
144 | $281.3M |
|
Q1 2021 13F
Filed May 13, 2021
|
127 | $233.8M |
|
Q4 2020 13F
Filed Feb 12, 2021
|
107 | $221.0M |
|
Q3 2020 13F
Filed Nov 13, 2020
|
96 | $170.4M |
|
Q2 2020 13F
Filed Aug 12, 2020
|
90 | $183.2M |
|
Q1 2020 13F
Filed May 13, 2020
|
120 | $158.5M |
|
Q4 2019 13F
Filed Feb 14, 2020
|
112 | $246.7M |
|
Q3 2019 13F
Filed Nov 12, 2019
|
116 | $238.0M |
|
Q2 2019 13F
Filed Aug 12, 2019
|
109 | $237.1M |
|
Q1 2019 13F
Filed May 13, 2019
|
108 | $250.9M |
|
Q4 2018 13F
Filed Feb 12, 2019
|
100 | $212.8M |
|
Q3 2018 13F
Filed Nov 13, 2018
|
104 | $308.2M |
|
Q2 2018 13F
Filed Aug 13, 2018
|
108 | $266.8M |
|
Q1 2018 13F
Filed May 11, 2018
|
106 | $242.6M |
|
Q4 2017 13F
Filed Feb 13, 2018
|
108 | $251.4M |
|
Q3 2017 13F
Filed Nov 13, 2017
|
107 | $233.9M |
|
Q2 2017 13F
Filed Aug 11, 2017
|
89 | $239.6M |
|
Q1 2017 13F
Filed May 12, 2017
|
78 | $207.8M |
|
Q4 2016 13F
Filed Feb 13, 2017
|
69 | $198.7M |
14 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q3 2019
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | LGND Ligand Pharmaceuticals Incorporated | $35.1M | 14.76% |
| 2 | SRCL Stericycle, Inc. | $16.0M | 6.72% |
| 3 | UPLD Upland Software, Inc. | $15.3M | 6.41% |
| 4 | FTAI Fortress Trans & Infrastructure Inv. LLC | $13.5M | 5.66% |
| 5 | APO Apollo Global Management, Inc. | $12.2M | 5.13% |
| 6 | MPLX MPLX LP | $10.3M | 4.31% |
| 7 | GOOG Alphabet Inc-Cl C | $9.6M | 4.05% |
| 8 | LKQ LKQ Corporation | $9.4M | 3.96% |
| 9 | FSK FS KKR Capital Corp. | $8.9M | 3.74% |
| 10 | BRSL International Gaming Technologies | $8.6M | 3.63% |
| 11 | TSG The Stars Group Inc. | $8.2M | 3.43% |
| 12 | CLMT Calumet Specialty Products Partners, LP | $7.4M | 3.09% |
| 13 | MIC Macquarie Infrastructure Corporation | $6.9M | 2.92% |
| 14 | PFE Pfizer Inc. | $4.7M | 1.99% |
| 15 | DAL Delta Air Lines, Inc. | $3.3M | 1.39% |
| 16 | FNMAT Fannie Mae 8.25 percent Series T | $3.0M | 1.28% |
| 17 | JPM JP Morgan Chase | $2.7M | 1.14% |
| 18 | CHCT Community Healthcare Trust Incorporated | $2.7M | 1.12% |
| 19 | ABBV AbbVie Inc. | $2.5M | 1.05% |
| 20 | EIGR Eiger BioPharmaceuticals, Inc. | $2.4M | 1.01% |
Values as reported on the Q3 2019 Form 13F. Every position is in the holdings table below.